Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2025 14.21M
June 30, 2025 13.74M
December 31, 2024 13.96M
June 30, 2024 14.11M
December 31, 2023 12.88M
June 30, 2023 10.27M
December 31, 2022 7.156M
June 30, 2022 7.424M
December 31, 2021 8.344M
June 30, 2021 9.273M
December 31, 2020 9.983M
June 30, 2020 8.801M
December 31, 2019 7.947M
June 30, 2019 7.106M
December 31, 2018 7.676M
June 30, 2018 6.101M
December 31, 2017 5.356M
June 30, 2017 5.513M
December 31, 2016 5.524M
Date Value
June 30, 2016 6.749M
December 31, 2015 5.727M
June 30, 2015 4.086M
December 31, 2014 4.426M
June 30, 2014 5.316M
December 31, 2013 4.307M
June 30, 2013 1.049M
December 31, 2012 0.7321M
June 30, 2012 2.362M
December 31, 2011 1.550M
June 30, 2011 -0.0075M
December 31, 2010 -1.410M
June 30, 2010 2.089M
December 31, 2009 3.431M
June 30, 2009 1.551M
December 31, 2008 0.8472M
June 30, 2008 1.107M
December 31, 2007 2.468M
June 30, 2007 2.170M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Smith & Nephew plc 1.330B
NexGel, Inc. -3.205M
AstraZeneca PLC 14.54B
GSK Plc 10.64B
IDEXX Laboratories, Inc. 1.368B